Sleep Aids Market Size, Share, Growth Analysis, By Product(Mattresses & pillows, medications, sleep apnea devices, and others), By Sleep-disorder(Insomnia, restless legs syndrome, sleep apnea, narcolepsy), By Region - Industry Forecast 2024-2031

Sleep Aids Market size was valued at USD 74.3 billion in 2019 and is poised to grow from USD 78.52 billion in 2023 to USD 124.97 billion by 2031, growing at a CAGR of 5.95% in the forecast period (2024-2031).

Sleep disorders are conditions that disrupt or weaken sleep patterns, giving rise to daytime sleepiness and other sleep aid symptoms. Inadequate sleep can cause problems in college, in addition to issues with work presentations, weight, thinking, mental health, interpersonal relationships, and the progression of heart disease and diabetes. Insomnia, sleep apnea, restless legs syndrome, and narcolepsy are some of the most widely known sleep disorders. Treatment options for sleep disorders include a variety of medicinal drugs medicines such as pitolisant, modafinil, and armodafinil, as well as supplements, therapy, and medications such as gabapentin, suvorexant, eszopiclone, zolpidem, melatonin, zaleplon, ramelteon, and Lemborexant. Some regular exercises and proper balance of light, noise, and temperature can play a vital role in sleep disorder; because exercises have a therapeutic effect on individuals who suffer from sleep disorders. However, the various side effects of sleep aids medicines on human health, as well as a vast number of patient medication expirations, are expected to impede market growth during the forecast period.

US Sleep Aids Market is poised to grow at a sustainable CAGR for the next forecast year.